DAX20.280 +2,5%ESt504.774 +2,5%Top 10 Crypto10,72 -2,5%Dow38.397 +1,1%Nas15.691 +0,6%Bitcoin71.022 -2,1%Euro1,0920 ±0,0%Öl63,99 -0,6%Gold2.987 +0,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Tesla A1CX3T Amazon 906866 Apple 865985 RENK RENK73 Infineon 623100 Allianz 840400 Lufthansa 823212 Mercedes-Benz Group (ex Daimler) 710000 BASF BASF11 Deutsche Bank 514000 BYD A0M4W9 Microsoft 870747 Volkswagen (VW) vz. 766403
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach Zollcrash: DAX letztlich mit starker Erholung -- Infineon kauft von Marvell zu -- Novo Nordisk investiert Milliarden in Brasilien -- Tilray, Conti, Tesla, Rüstungsaktien, Porsche im Fokus
Top News
Carvana ist kurzfristiger Profiteur der US-Zölle auf Autoimporte Carvana ist kurzfristiger Profiteur der US-Zölle auf Autoimporte
Intuitive Surgical (ISRG) – Der Pionier der Roboterchirurgie mit enormem Zukunftspotential! Intuitive Surgical (ISRG) – Der Pionier der Roboterchirurgie mit enormem Zukunftspotential!
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Gilead Sciences Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
97,59 EUR +2,07 EUR +2,17 %
FSE
105,60 USD +0,10 USD +0,09 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.119,91 Mrd. EUR

KGV241,49Div. Rendite3,33%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN885823

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS3755581036

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolGILD

Gilead Sciences Aktien News

DatumMeistgelesen
ZacksGilead (GILD) Announces Positive Interim Results on PBC Drug
BenzingaDecoding Gilead Sciences's Options Activity: What's the Big Picture?
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
BenzingaGilead Sciences Unusual Options Activity For May 06
BenzingaHow Is The Market Feeling About Gilead Sciences?
ZacksThe Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
ZacksGilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
BenzingaGilead Sciences Unusual Options Activity
ZacksGilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
MotleyFoolGilead Sciences (GILD) Q1 2024 Earnings Call Transcript
ZacksGilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
ZacksGilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates
ZacksGilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
ZacksInsights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics
ZacksGilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
BenzingaThe Analyst Verdict: Gilead Sciences In The Eyes Of 12 Experts
ZacksGilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
BenzingaWhat the Options Market Tells Us About Gilead Sciences
ZacksAnalysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
PR NewswireGILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
PR NewswireGILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA
PR NewswireGILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN HONG...
ZacksGilead Sciences (GILD) Stock Moves -0.84%: What You Should Know
ZacksGilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider
BenzingaStarbucks, Gilead And Ambev Are At 52-Week Lows: Should You Buy The Dip?
PR NewswireRedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola
PR NewswireARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP
PR NewswireGILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION'S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030
PR NewswireCognizant and Gilead Extend Partnership with Five-Year Service Agreement Estimated at $800 Million
PR NewswireArcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma
RSSForm 4 882095
RSSForm 10-Q 882095
RSSForm 8-K 882095
RSSStatement of acquisition of beneficial ownership by individuals
RSSInitial statement of beneficial ownership of securities
PR NewswireEverest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients
PR NewswireEverest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients
RSSForm S-8 882095
RSSForm 4 882095
Wer­bung

Gilead Sciences News

Gilead Sciences News: auf dieser Seite finden Sie alle Gilead Sciences News und Nachrichten zur Gilead Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Gilead Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Gilead Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.